According to the official website of the Beijing Municipal People's Government, in order to accelerate the cultivation of new quality productivity and to build Beijing into an internationally influential "Artificial Intelligence + Pharmaceutical Health" innovation hub, the Beijing Municipal Science and Technology Commission, the Management Committee of Zhongguancun Science Park, the Beijing Municipal Health Commission, and other departments jointly formulated the "Action Plan for Accelerating the Innovative Development of 'Artificial Intelligence + Pharmaceutical Health' in Beijing." Since 2025, several AI medical concept stocks have performed well, with Berry Genomics, LBPMedicin, and Xinlitai leading the gains at 73.37%, 69.83%, and 55.34%, respectively; Winning Health, Ailong Technology, Hongbo Pharmaceutical, WuXi AppTec, and Dian Diagnostics have all seen gains exceeding 30%